News

Categories
  1. Donanemab's approval around the world: How long will you have to wait?

    When will the new Alzheimer's medicine get its approval? And how long until it gets to your country?

    Read more »
  2. Nidlegy's approval (FDA, EMA, MHRA and more): How long will you have to wait?

    When is the new treatment for melanoma getting its first global approval? Here's what you need to know.

    Read more »
  3. Dato dxd for breast cancer and lung cancer: When is approval coming?

    When is Dato dxd's EMA approval expected, and what is the fastest way to access this breast and lung cancer treatment?

    Read more »
  4. Linvoseltamab's approval by the EMA (and FDA): How long will you have to wait?

    When will the latest treatment for multiple myeloma get approval - from the EMA, MHRA, and more?

    Read more »
  5. Resminostat's approval by the EMA (and the FDA, MHRA and more): How long will you have to wait?

    When will the newest treatment for cutaneous T-cell lymphoma be available in Europe, the UK, and beyond?

    Read more »
  6. Lazertinib's EMA approval: When will it be available in Europe, the UK, and worldwide?

    When will the new treatment for lung cancer with EGFR and T790M mutations become available in Europe, the UK, and beyond?

    Read more »
  7. Vorasidenib's EMA Approval: When Will It Be Available in Europe, the UK, and Worldwide?

    When will the newest treatment for low-grade glioma become available - in Europe, the UK, and beyond?

    Read more »
  8. Lurbinectedin for Ewing sarcoma and neuroendocrine tumors: Are we there yet?

    Can lurbinectedin be used to treat Ewing sarcoma and neuroendocrine tumors? The latest data and likely approval timelines.

    Read more »
  9. Relyvrio Discontinued: Top Alternatives and How to Continue Your Treatment

    Relyvrio is being pulled off the market. What does it mean for you and your treatment?

    Read more »
  10. Who is a candidate for lecanemab (and how to get the treatment if you qualify)?

    Who qualifies for treatment with lecanemab? And how non-US patients can get the medicine if their doctor prescribes it.

    Read more »
  11. Fruquintinib for gastric cancer: Will it be approved soon?

    Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?

    Read more »
  12. Nirogacestat: What is the new treatment for desmoid tumors?

    All you need to know about Ogsiveo (nirogacestat) and what it could mean for your desmoid tumor treatment.

    Read more »
  13. Lurbinectedin's EMA approval: Is it coming (and when)?

    Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.

    Read more »
  14. Givinostat's role in polycythemia vera treatment: All you need to know

    Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.

    Read more »
  15. Givinostat's EMA approval: How long do you have to wait (and how not to)?

    When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?

    Read more »
  16. Leniolisib's EMA approval: How to prevent delays from delaying your treatment

    When will Joenja be approved (and available) in Europe and the UK? Including how to avoid waiting.

    Read more »
  17. What types of cancer can Tivdak treat? The latest trial data.

    Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.

    Read more »
  18. Eflornithine for neuroblastoma: EMA approval timelines and how to avoid waiting

    When will European patients have access to the newest FDA-approved neuroblastoma treatment?

    Read more »
  19. Iptacopan's EMA approval is near. When will the medicine be available to you?

    Iptacopan will soon be approved in Europe, but when will it be available to patients?

    Read more »
  20. Retifanlimab for renal cell carcinoma (and other types of cancer)

    Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.

    Read more »
  21. Everything about eplontersen's EMA approval (and how to get the treatment sooner)

    When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.

    Read more »
  22. What types of cancer can toripalimab treat?

    Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

    Read more »
  23. Can erdafitinib treat breast cancer? The latest data, in simple terms.

    Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

    Read more »
  24. When is toripalimab getting its EMA approval (and how not to wait)

    Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

    Read more »
  25. Tivdak's EMA approval: When is it coming (and what to do if you can't wait)

    When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

    Read more »
  26. Zynyz's EMA approval: When will the treatment be available (and how not to wait)

    Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

    Read more »
  27. Erdafitinib's EMA approval: Where are we five years after its first global approval

    Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

    Waiting for erdafitinib's EMA approvalWaiting for erdafitinib's EMA approval
    Read more »
  28. What types of cancer can tazemetostat treat? The latest research.

    Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.

    Read more »
  29. Tazemetostat's EMA approval: What if waiting is no option?

    Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.

    Read more »
  30. Discover the latest psoriasis creams approved for children [2024]

    Stay updated on the latest psoriasis creams approved for children in 2024. Learn about the safest and most effective treatments available for your child's skin condition.

    Read more »
Page
US 0